scholarly article | Q13442814 |
P356 | DOI | 10.1055/S-2007-1019628 |
P953 | full work available at URL | http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2007-1019628.pdf |
P698 | PubMed publication ID | 6108577 |
P2093 | author name string | L. Tondo | |
G. Serra | |||
A. Kukopulos | |||
D. Reginaldi | |||
G. Floris | |||
P. Laddomada | |||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 156-167 | |
P577 | publication date | 1980-07-01 | |
P1433 | published in | Pharmakopsychiatrie, Neuro-Psychopharmakologie | Q27712617 |
P1476 | title | Course of the manic-depressive cycle and changes caused by treatment | |
Course of the Manic-Depressive Cycle and Changes Caused by Treatments | |||
P478 | volume | 13 |
Q52932623 | A meta-analysis of the use of typical antipsychotic agents in bipolar disorder. |
Q41189037 | A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures |
Q92892412 | A systematic review and meta-analysis of clinical predictors of lithium response in bipolar disorder |
Q22242646 | A systematic review of the evidence on the treatment of rapid cycling bipolar disorder |
Q35236966 | Acute and long-term treatment of mania. |
Q44804255 | Adjunct treatments in acute mania |
Q36466842 | Adjunctive treatment of acute mania with risperidone versus typical antipsychotics: a retrospective study. |
Q36551594 | Age transitions in the course of bipolar I disorder |
Q44335284 | Alcohol dependence and mood disorders |
Q42645137 | An open longitudinal study of patients with bipolar rapid cycling treated with lithium or lamotrigine for mood stabilization |
Q35664266 | Anticonvulsant Use in the Treatment of Bipolar Disorder: A Primer for Primary Care Physicians |
Q38899735 | Antidepressant-Induced Dopamine Receptor Dysregulation: A Valid Animal Model of Manic-Depressive Illness |
Q34448125 | Antidepressant-associated hypomania in outpatient depression: a 203-case study in private practice |
Q73437213 | Antidepressant-associated mania in late life |
Q60048075 | Antidepressants in bipolar depression: an enduring controversy |
Q40095757 | Approaches to the Evaluation and Treatment of Rapid-Cycling Affective Illness |
Q39305694 | Athanasios Koukopoulos' Psychiatry: The Primacy of Mania and the Limits of Antidepressants. |
Q38873600 | Athanasios Koukopoulos' psychiatry: The primacy of mania and the uselessness of antidepressants |
Q35073763 | Atypical antipsychotics and mood stabilization in bipolar disorder |
Q50558688 | Bipolar II illness: course and outcome over a five-year period. |
Q35017636 | Bipolar depression: management options |
Q82235766 | Bipolar disorder |
Q34977053 | Bipolar disorder detection, ascertainment, and treatment: primary care physician knowledge, attitudes, and awareness |
Q26795404 | Bipolar disorder in women |
Q34052830 | Bipolar disorder therapeutics: maintenance treatment |
Q27010258 | Bipolar spectrum: a review of the concept and a vision for the future |
Q33957680 | Bipolarity from ancient to modern times: conception, birth and rebirth |
Q34547113 | Clinical correlates of therapeutic response in bipolar disorder |
Q92061330 | Clinical use of lithium salts: guide for users and prescribers |
Q33744368 | Comparative pharmacology of bipolar disorder and schizophrenia |
Q35212332 | Concepts in the treatment of bipolar disorder. |
Q40866452 | Continuation and maintenance pharmacotherapy for unipolar and bipolar mood disorders. |
Q39178954 | Continuous circular cycling as a predictor of treatment response in bipolar disorders: a comprehensive review of the current literature |
Q34108459 | Current concepts in rapid cycling bipolar disorder |
Q35236993 | Current issues: women and bipolar disorder |
Q34521351 | Current research on rapid cycling bipolar disorder and its treatment |
Q41638850 | Depression and Mania in Bipolar Disorder |
Q48057165 | Depression following mania |
Q54146505 | Divalproate augmentation in lithium-resistant rapid cycling mania in four geriatric patients. |
Q39410022 | Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression |
Q42671085 | Do patients with borderline personality disorder belong to the bipolar spectrum? |
Q44266754 | Duration and stability of the rapid-cycling course: a long-term personal follow-up of 109 patients |
Q34217217 | ECNP Consensus Meeting March 2000 Nice: guidelines for investigating efficacy in bipolar disorder. European College of Neuropsychopharmacology |
Q36442497 | Early improvement with lithium in classic mania and its association with later response |
Q40736450 | Effects of rapid cycling on response to lithium maintenance treatment in 360 bipolar I and II disorder patients |
Q33572123 | Empirical typology of bipolar I mood episodes |
Q50858416 | Estrogen, serotonin, and mood disturbance: where is the therapeutic bridge? |
Q73308911 | First International Exchange on Bipolar Disorder |
Q41638900 | Free Interval Duration: Clinical Evidence of the Primary Role of Excitement in Bipolar Disorder |
Q47407217 | Frequency of hospitalisations and inpatient care costs of manic episodes: in patients with bipolar I disorder in France |
Q39502405 | Functional genetic variation in the Rev-Erbα pathway and lithium response in the treatment of bipolar disorder. |
Q34057133 | Functional impairment and cognition in bipolar disorder |
Q35561522 | Gender differences in bipolar disorder |
Q51891488 | Gender differences in major depressive disorder and bipolar disorder. |
Q50881952 | Gender differences in patients with bipolar disorder influence outcome in the medical outcomes survey (SF-20) subscale scores. |
Q33920209 | Historical perspectives and natural history of bipolar disorder |
Q37547264 | Identification of Susceptible Loci and Enriched Pathways for Bipolar II Disorder Using Genome-Wide Association Studies |
Q34503731 | Is bipolar disorder still underdiagnosed? Are antidepressants overutilized? |
Q35212737 | Issues in the treatment of bipolar disorder |
Q36233958 | Lamotrigine adjunctive therapy to lithium and divalproex in depressed patients with rapid cycling bipolar disorder and a recent substance use disorder: a 12-week, double-blind, placebo-controlled pilot study |
Q36916509 | Longitudinal course of bipolar I disorder: duration of mood episodes |
Q44464135 | Maintenance efficacy of divalproex in the prevention of bipolar depression |
Q34106695 | Maintenance therapies for classic and other forms of bipolar disorder |
Q35132693 | Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication |
Q26852133 | Memantine: New prospective in bipolar disorder treatment |
Q44266760 | Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling |
Q34349641 | Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis |
Q34106689 | Pharmacotherapy of depression and mixed states in bipolar disorder. |
Q52918538 | Polarity of the first episode, clinical characteristics, and course of manic depressive illness: a systematic retrospective investigation of 320 bipolar I patients. |
Q36123888 | Progression of female reproductive stages associated with bipolar illness exacerbation |
Q34313479 | Psychotic and mood disorders associated with the perimenopausal period: epidemiology, aetiology and management |
Q77993014 | Rapid cycling affective disorder: a descriptive study from North India |
Q22242605 | Rapid cycling bipolar disorder - diagnostic concepts |
Q36177621 | Rapid cycling bipolar disorder: clinical characteristics and treatment options |
Q33768223 | Rapid-cycling bipolar disorder. An overview of research and clinical experience |
Q35154713 | Rapid-cycling bipolar disorder: effects of long-term treatments |
Q43931805 | Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers |
Q35146063 | Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). |
Q34106678 | Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders |
Q35036680 | Redefining mood stabilization |
Q77790335 | Response to lithium maintenance treatment in bipolar disorders: comparison of women and men |
Q35884680 | Rethinking the treatment paradigm for bipolar depression: the importance of long-term management |
Q40775549 | Retrospective controlled study of inpatient ECT: does it prevent suicide? |
Q36581155 | Risk of Psychiatric Disorders Following Symptomatic Menopausal Transition: A Nationwide Population-Based Retrospective Cohort Study |
Q31951578 | Social anxiety, hypomania and the bipolar spectrum: data, theory and clinical issues |
Q36096615 | Subthreshold bipolarity: diagnostic issues and challenges |
Q31951593 | Systematic clinical methodology for validating bipolar-II disorder: data in mid-stream from a French national multi-site study (EPIDEP). |
Q28076486 | The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and Methods of the Development of Guidelines |
Q30583384 | The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders |
Q33723078 | The bipolar spectrum: a clinical reality in search of diagnostic criteria and an assessment methodology |
Q51789654 | The clinical history and costs associated with delayed diagnosis of bipolar disorder. |
Q35142731 | The effect of lithium in bipolar disorder: a review of recent research evidence |
Q63446703 | The efficacy of lamotrigine in rapid cycling and non–rapid cycling patients with bipolar disorder |
Q34185336 | The impact of lithium prophylaxis on the course of bipolar disorder: a review of the research evidence |
Q41361361 | The noradrenaline metabolite MHPG is a candidate biomarker between the depressive, remission, and manic states in bipolar disorder I: two long-term naturalistic case reports |
Q33817419 | The noradrenaline metabolite MHPG is a candidate biomarker from the manic to the remission state in bipolar disorder I: a clinical naturalistic study |
Q45959644 | The pharmacogenetics of lithium response depends upon clinical co-morbidity. |
Q36170788 | The phenotypes of bipolar disorder: relevance for genetic investigations |
Q37980516 | The role of antipsychotics in the management of fibromyalgia |
Q33878237 | The role of gender in mixed mania |
Q38025454 | The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence |
Q33962900 | The soft bipolar spectrum redefined: focus on the cyclothymic, anxious-sensitive, impulse-dyscontrol, and binge-eating connection in bipolar II and related conditions |
Q73617031 | The treatment of bipolar depression |
Q39886182 | Transitions: Athanasios Koukopoulos [AθανάσιΟς κΟυκόπΟυλΟς], M.D. (1931-2013). |
Q39287194 | Treatment of Bipolar Disorder in a Lifetime Perspective: Is Lithium Still the Best Choice? |
Q37973144 | Treatment of mixed bipolar states |
Q35613758 | Treatment of non-schizophrenic disorders: focus on atypical antipsychotics |
Q34969649 | Treatment research in bipolar disorder: issues and recommendations |
Q41127918 | Treatment-resistant bipolar depression |
Q40089146 | Use of the anticonvulsant carbamazepine in primary and secondary affective illness: clinical and theoretical implications |
Q39004427 | What is the role of conventional antidepressants in the treatment of major depressive episodes with Mixed Features Specifier? |
Q38786807 | Who's the Leader, Mania or Depression? Predominant Polarity and Alcohol/Polysubstance Use in Bipolar Disorders |
Q41733999 | Women's mental health in primary care. Depression, anxiety, somatization, eating disorders, and substance abuse |
Q79351258 | [Treatment of bipolar disorders] |
Search more.